Partnership for Safe Medicines also notes Eli Lilly suing five more retatrutide sellers and FDA staff concerns over a plan to let compounders dispense unapproved peptides.
Recap by typeshit. Full story at Partnership for Safe Medicines.
European regulators first raised NAION, a rare optic nerve condition sometimes called an eye stroke, as a possible risk more than 15 months ago.
Users described more appetite, fatigue, extra energy and insomnia. An analysis of Reddit comments, not a clinical trial, so the findings come from self-reports.
Online sellers pitch peptides for weight loss, anti-aging and muscle gain, and Gavin Coote's full story looks at the risks of products nobody regulates.
A surgeon on social media says the FDA has received two death reports involving black-market retatrutide. No official FDA statement is linked.
The Swiss drugmaker is taking on the Chinese biotech's investigational obesity drug, Reuters reports, adding to the rush of big pharma obesity deals.
The Swiss drugmaker is licensing an investigational obesity candidate from the Chinese biotech, Reuters reports.
Loading…